Reshuffles in Pharma & CROs To Affect Research Collab

 Predictions for Q4 2025-Q1 2026 indicate significant workforce reshuffles in pharmaceuticals and CROs (Contract Research Organisations), which could indirectly affect research collaborations with ICMR or scientific units. This trend points to cost-cutting and restructuring amid economic pressures.

 

Send Feedback

 
More Bureaucracy News
Load more